Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cord Partners, Inc. was a biotechnology and healthcare services company specializing in the collection, processing, and long-term preservation of umbilical cord blood stem cells. Operating as a subsidiary of Cord Blood America, Inc., the company provided private cord blood banking services to families, allowing them to store hematopoietic stem cells for potential future use in treating various blood-related and genetic disorders. The company's business model relied on direct-to-consumer marketing and strategic partnerships with obstetricians and hospitals to facilitate the collection of cord blood at birth. Following a series of corporate restructurings, its assets were eventually acquired and integrated into larger stem cell preservation entities, ultimately becoming part of the Generate Life Sciences portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cord Partners.